atements of historical fact are,
or may be deemed to be, forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. These forward-looking
statements are not based on historical facts, but rather reflect our
current expectations and projections about our future results, performance,
prospects and opportunities. We have tried to identify these
forward-looking statements by using words including "may," "will,"
"expect," "anticipate," "believe," "intend," "estimate," "continue" and
similar expressions. These forward- looking statements are subject to a
number of risks, uncertainties and other factors that could cause our
actual results, performance, prospects or opportunities, as well as those
of the markets we serve or intend to serve, to differ materially from those
expressed in, or implied by, these forward- looking statements. The
following important factors, among others, could affect our business and
financial performance: our ability to complete, integrate and benefit from
acquisitions, divestitures, joint ventures and strategic alliances;
estimated demand for the commodities and other products that we sell and
use in our business; industry conditions, including the cyclicality of the
agribusiness industry and unpredictability of the weather; agricultural,
economic and political conditions in the primary markets where we operate;
and other economic, business, competitive and/or regulatory factors
affecting our business generally. The forward-looking statements included
in this release are made only as of the date of this release, and except as
otherwise required by federal securities law, we do not have any obligation
to publicly update or revise any forward-looking statements to reflect
subsequent events or circumstances.
Additional Financial Information
The following table provides a summary of certain gains and charges
that may be of i
'/>"/>
SOURCE Bunge Limited Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Related biology technology :1.
Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months2.
ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year3.
Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies4.
Recent Research Reports and Near-Term Corporate Events5.
Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results6.
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 20087.
Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History8.
Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter9.
Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year10.
CuraGen Reports Fourth Quarter and Year End 2007 Financial Results11.
Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%